Goff DC. Response to the Letter to the Editor by Dr Reynolds, Xanomeline/Trospium
Combination: Not Non-Dopaminergic but a Novel Antidopaminergic Treatment for
Schizophrenia. J Clin Psychopharmacol 2025 Aug 11. doi: 10.1097/JCP.0000000000002029.
PMID: 40790979
|